A5052349175- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Impact on Reproduction
- Pregnancy and Medication Impact
- Long-Term Effects of COVID-19
- Reproductive System and Pregnancy
- Pneumocystis jirovecii pneumonia detection and treatment
- Antifungal resistance and susceptibility
- Antibiotics Pharmacokinetics and Efficacy
- Urinary Tract Infections Management
- Antibiotic Resistance in Bacteria
- HIV/AIDS oral health manifestations
- Drug-Induced Adverse Reactions
- Tryptophan and brain disorders
- HIV Research and Treatment
- Alzheimer's disease research and treatments
- Diabetes Management and Research
- Diabetes and associated disorders
- Pregnancy and preeclampsia studies
- SARS-CoV-2 detection and testing
University of Naples Federico II
2022-2024
Federico II University Hospital
2022-2023
Urinary tract infections (UTIs) are the second most frequent type of infection observed in clinical practice. Gram-negative Enterobacteriaceae common pathogens UTIs. Excessive antibiotic use humans and animals, poor control, increased global travel have accelerated spread multidrug-resistant strains (MDR). Carbapenem antibiotics commonly considered last line defense against MDR bacteria; however, their efficacy is now threatened by increasing prevalence carbapenem-resistant (CRE). This...
Pneumocystis jirovecii pneumonia (PJP) is an invasive fungal infection (IFI) that occurs mainly in immunocompromised hosts. After observing a high prevalence of PJP as complication COVID-19 immunocompetent patients, we conducted study to evaluate the P. colonization with PCR on oral washing samples (OWS) among non-immunocompromised and non-critical patients admitted at our university hospital.All over 18 years age Infectious Diseases Unit for SARS-CoV-2 between July 2021 December 2022 were...
More than 2 years after the pandemic, availability of vaccination and use monoclonal antibodies direct antivirals have changed fate COVID-19, allowing for a better management disease, reducing hospitalization rates, improving survival. This study aims to describe outcome COVID-19 in cohort solid organ transplant recipients impact novel against SARS-CoV-2. We conducted an observational retrospective study. enrolled with attending A.O.U. Federico II Naples followed up from January 2022 July...
BACKGROUND
 Pneumocystis jirovecii pneumonia (PJP) is an invasive fungal infection (IFI) that occurs mainly in immunocompromised hosts. As we observed a high prevalence of PCP as complication COVID-19 immunocompetent patients, conducted study to evaluate the P. colonization with PCR on oral washing samples (OWS) among non-immunocompromised and non-critical patients admitted for at our University Hospital.
 METHODS
 All over 18 years age Infectious Diseases Unit SARS-CoV-2...
Despite the lightning-fast advances in management of SARS-CoV after 2 years pandemic, COVID-19 continues to pose a challenge for fragile patients, who could benefit from early administration monoclonal antibodies (mAbs) reduce risk severe disease progression. We conducted prospective study evaluate effectiveness mAbs against SARS-CoV-2 among patients at progression, namely elderly and those with comorbidities, before omicron variant surge. Patients were treated either casirivimab/imdevimab,...
Diabetes mellitus represents one of the most frequent comorbidities among patients with COVID-19, constituting a risk factor for more severe prognosis than that non-diabetic patients. However, pathophysiological mechanism underlying this unfavorable outcome is still not completely clear. The goal our study was to evaluate potential role antidiabetic therapy in evolution COVID-19.
The aim of this study was to report the use casirivimab/imdevimab therapy in pregnant women with moderate coronavirus disease 2019 (COVID-19).
Abstract Despite the lightning-fast advances in management of SARS-CoV after 2 years pandemic, COVID-19 continues to pose a challenge for fragile patients, who could benefit from early administration monoclonal antibodies (mAbs) reduce risk severe disease progression. We conducted prospective study evaluate effectiveness mAbs against SARS-CoV-2 among patients at progression, namely elderly and those with comorbidities, before omicron variant surge. Patients were treated either...
Abstract Objective Our objective was to evaluate the safety and efficacy of casirivimab/imdevimab therapy in pregnant women with severe coronavirus disease 2019 (COVID-19) requiring oxygen therapy. Study Design This a prospective case series study aimed unvaccinated COVID-19. Inclusion criteria were acute respiratory syndrome 2 infection documented polymerase chain reaction, pregnancy, COVID-19 therapy, duration symptoms 10 days or less, able provide informed consent. Vaccinated those...